Financhill
Sell
13

MRM Quote, Financials, Valuation and Earnings

Last price:
$0.80
Seasonality move :
-4.86%
Day range:
$0.79 - $0.85
52-week range:
$0.76 - $8.39
Dividend yield:
0%
P/E ratio:
48.31x
P/S ratio:
0.09x
P/B ratio:
18.16x
Volume:
16.7K
Avg. volume:
53.2K
1-year change:
-86.53%
Market cap:
$6.3M
Revenue:
$48.7M
EPS (TTM):
-$0.12

Analysts' Opinion

  • Consensus Rating
    MEDIROM Healthcare Technologies has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $4.98, MEDIROM Healthcare Technologies has an estimated upside of 523.05% from its current price of $0.80.
  • Price Target Downside
    According to analysts, the lowest downside price target is $4.98 representing 100% downside risk from its current price of $0.80.

Fair Value

  • According to the consensus of 1 analyst, MEDIROM Healthcare Technologies has 523.05% upside to fair value with a price target of $4.98 per share.

MRM vs. S&P 500

  • Over the past 5 trading days, MEDIROM Healthcare Technologies has underperformed the S&P 500 by -9.12% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • MEDIROM Healthcare Technologies does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • MEDIROM Healthcare Technologies has grown year-over-year revenues for 0 quarters straight. In the most recent quarter MEDIROM Healthcare Technologies reported revenues of --.

Earnings Growth

  • MEDIROM Healthcare Technologies has grown year-over-year earnings for 0 quarters straight. In the most recent quarter MEDIROM Healthcare Technologies reported earnings per share of --.
Enterprise value:
15.4M
EV / Invested capital:
--
Price / LTM sales:
0.09x
EV / EBIT:
171.60x
EV / Revenue:
0.33x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-1.32x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
11.64x
Gross Profit (TTM):
$10.2M
Return On Assets:
-1.31%
Net Income Margin (TTM):
-1.17%
Return On Equity:
--
Return On Invested Capital:
-6.44%
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2023-02-21 2024-02-21 2024-02-21
Income Statement
Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
Operating Income -- -- -- -- --
EBITDA -- -- -- -- --
Diluted EPS -- -- -- -- --
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Balance Sheet
Current Assets $7M $7.9M $9M $10.8M $6.9M
Total Assets $38.1M $47M $40.2M $41.8M $36.2M
Current Liabilities $18.8M $22.1M $23.2M $22.6M $20.5M
Total Liabilities $36.6M $45.2M $43M $44.7M $38.5M
Total Equity $1.5M $1.9M -$2.9M -$2.9M -$2.3M
Total Debt $6.9M $6.8M $6.2M $8.3M $10M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-02-21 2024-02-21 2024-02-21
Cash Flow Statement
Cash Flow Operations -- -- -- -- --
Cash From Investing -- -- -- -- --
Cash From Financing -- -- -- -- --
Free Cash Flow -- -- -- -- --
MRM
Sector
Market Cap
$6.3M
$445.5M
Price % of 52-Week High
9.54%
73.1%
Dividend Yield
0%
0%
Shareholder Yield
--
3.66%
1-Year Price Total Return
-86.53%
-11.95%
Beta (5-Year)
--
0.952
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Sell
Level $0.87
200-day SMA
Sell
Level $3.18
Bollinger Bands (100)
Sell
Level 1.03 - 2.97
Chaikin Money Flow
Sell
Level -55.9M
20-day SMA
Sell
Level $0.90
Relative Strength Index (RSI14)
Sell
Level 33.77
ADX Line
Sell
Level 31.76
Williams %R
Buy
Level -80.196
50-day SMA
Sell
Level $1.10
MACD (12, 26)
Sell
Level -0.09
25-day Aroon Oscillator
Sell
Level -88
On Balance Volume
Neutral
Level 83.3M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (1.0868)
Sell
CA Score (Annual)
Level (-2.2938)
Sell
Beneish M-Score (Annual)
Level (-1.7)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (5.3487)
Sell
Piotroski F Score (Annual)
Level (2)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Company Profile

MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.

Stock Forecast FAQ

In the current month, MRM has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MRM average analyst price target in the past 3 months is $4.98.

  • Where Will MEDIROM Healthcare Technologies Stock Be In 1 Year?

    According to analysts, the consensus estimate is that MEDIROM Healthcare Technologies share price will rise to $4.98 per share over the next 12 months.

  • What Do Analysts Say About MEDIROM Healthcare Technologies?

    Analysts are divided on their view about MEDIROM Healthcare Technologies share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that MEDIROM Healthcare Technologies is a Sell and believe this share price will drop from its current level to $4.98.

  • What Is MEDIROM Healthcare Technologies's Price Target?

    The price target for MEDIROM Healthcare Technologies over the next 1-year time period is forecast to be $4.98 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is MRM A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for MEDIROM Healthcare Technologies is a Buy. 1 of 1 analysts rates the stock a Buy at this time.

  • How Can I Buy Shares Of MRM?

    You can purchase shares of MEDIROM Healthcare Technologies via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase MEDIROM Healthcare Technologies shares.

  • What Is The MEDIROM Healthcare Technologies Share Price Today?

    MEDIROM Healthcare Technologies was last trading at $0.80 per share. This represents the most recent stock quote for MEDIROM Healthcare Technologies. Yesterday, MEDIROM Healthcare Technologies closed at $0.80 per share.

  • How To Buy MEDIROM Healthcare Technologies Stock Online?

    In order to purchase MEDIROM Healthcare Technologies stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Is SoFi Worth?
What Is SoFi Worth?

Since SoFi’s CEO began snapping up shares of the student…

Is CVX a Buy, Sell or Hold?
Is CVX a Buy, Sell or Hold?

Energy giant Chevron Corporation (NYSE:CVX) has long been a pure-play…

What Will NVIDIA Stock Be Worth in 2030?
What Will NVIDIA Stock Be Worth in 2030?

NVIDIA (NASDAQ:NVDA) has been by far one of the best…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Sell
5
TRUP alert for Feb 21

Trupanion [TRUP] is down 7.18% over the past day.

Sell
12
TFII alert for Feb 21

TFI International [TFII] is down 6.67% over the past day.

Sell
22
FRPT alert for Feb 21

Freshpet [FRPT] is down 5.76% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock